stockrow
Friday 6 November 2026
Export HIMS’s income statement to Excel — free account
Hims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.
- Revenue
- +38.3%
- EPS
- −294.7%
- Free cash flow
- +5.09%
- Total debt
- +40.8%
Quarter to June 2026, against a year earlier
24.11
2.55
−9.56%
Follow HIMS
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 6 | 6 | — | 4 | — | — | — | — |
P/E ratio |
56.96 | 41.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 198.00 | 198.00 |
Altman Z-Score |
4.10 | 15.76 | 12.57 | 14.46 | 14.16 | 7.90 | 17.49 | 0.97 | 13.37 | 0.28 |
P/S ratio |
3.11 | 3.54 | 2.31 | 2.45 | 4.64 | 4.50 | 3.73 | 3.47 | 0.00 | 0.00 |
P/FCF ratio |
98.76 | 24.93 | 35.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
1.62 | 3.26 | 3.17 | 4.69 | 3.44 | 3.06 | 1.22 | (0.73) | 6.88 | (2.31) |
P/Operating CF |
119.14 | 60.44 | 91.80 | (192.37) | (406.05) | (394.02) | (2,060.78) | (1,918.84) | (1,443.68) | (1,443.68) |
P/B ratio |
13.50 | 10.95 | 5.87 | 4.15 | 3.77 | 3.66 | 0.00 | 0.00 | 0.25 | 0.25 |
Price to Tangible BV |
109.86 | 16.29 | 9.41 | 7.22 | 6.37 | 6.18 | 0.00 | 0.00 | 0.25 | 0.25 |
EV/Sales |
3.28 | 3.33 | 2.06 | 2.12 | 3.74 | 3.61 | 3.05 | 2.80 | 0.00 | 0.00 |
EV/EBITDA |
47.35 | 65.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
25.66 | 19.61 | 24.49 | (42.09) | (29.57) | (28.49) | (183.20) | (167.79) | 0.00 | 0.00 |
EV/FCF |
104.10 | 23.51 | 31.99 | (38.18) | (28.87) | (27.81) | (107.72) | (98.66) | 0.00 | 0.00 |
Quick Ratio |
1.43 | 1.36 | 2.50 | 3.75 | 3.75 | 3.12 | 3.12 | 6.58 | 6.58 | 1.54 |
Current Ratio |
1.90 | 1.79 | 3.00 | 4.52 | 4.52 | 3.41 | 3.41 | 7.43 | 7.17 | 1.69 |
Net Debt/EBITDA |
2.43 | (4.02) | 8.62 | 2.94 | 0.00 | 2.28 | 0.00 | 7.46 | 7.11 | 0.02 |
Debt/Assets |
45.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
1.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.64 | 2.57 | 2.16 | 1.34 | 0.00 | 1.01 | 0.00 | 0.92 | 0.00 | 0.81 |
Operating CF/Net income |
2.34 | 1.99 | (3.12) | 0.40 | 0.40 | 0.32 | 0.32 | 0.14 | 0.14 | 1.04 |
Capex/Depreciation |
(3.97) | (3.27) | (4.50) | (0.36) | 0.00 | (0.13) | 0.00 | (1.02) | 0.00 | (2.37) |
Interest Coverage |
— | — | — | — | — | — | — | (1,514.40) | (5.50) | (201.66) |
| 25.23% | 30.71% | (7.18%) | (20.32%) | 0.00% | (114.69%) | 0.00% | 25.54% | 0.00% | (75.36%) | |
| 8.97% | 21.94% | (5.83%) | (16.69%) | 0.00% | (39.93%) | 0.00% | (11.20%) | 0.00% | (70.39%) | |
ROIC |
7.05% | 21.92% | (14.96%) | (32.50%) | 0.00% | (82.32%) | 0.00% | 0.00% | 0.00% | (1,332.74%) |
Return on Tangible Assets |
19.01% | 49.13% | (11.07%) | (36.52%) | (37.84%) | (56.46%) | 0.00% | (18.51%) | (19.29%) | (10,622.64%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
6.36% | 5.34% | 5.53% | 5.55% | 0.00% | 8.23% | 0.00% | 7.55% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
50.78% | 57.34% | 66.09% | 70.37% | 89.15% | 91.79% | 116.03% | 57.15% | 83.05% | 144.16% |
Intangible Assets out of Total Assets |
0.22 | 0.22 | 0.29 | 0.36 | 0.36 | 0.33 | 0.33 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
5.76% | 6.25% | 7.58% | 8.13% | 0.00% | 24.72% | 0.00% | 3.92% | 0.00% | 9.72% |
Graham Net Nets |
(0.12) | 0.03 | 0.08 | 0.13 | 0.15 | 0.15 | (0.28) | (0.30) | (0.13) | (0.13) |
Graham Number |
5.55 | 5.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.92 | 0.00 | 0.00 |
Earnings Yield |
1.76% | 2.40% | (1.18%) | (5.06%) | (9.19%) | (9.47%) | (3.27%) | (3.51%) | 0.51% | 0.51% |
Free Cash Flow Yield |
1.01% | 4.01% | 2.79% | (2.26%) | (2.80%) | (2.88%) | (0.76%) | (0.82%) | 0.00% | 0.00% |
Revenue per Share |
10.44 | 6.84 | 4.17 | 2.58 | 2.58 | 1.46 | 1.46 | 4.21 | 4.21 | 2.38 |
Operating CF per Share |
1.33 | 1.16 | 0.35 | (0.13) | (0.13) | (0.18) | (0.18) | (0.07) | (0.07) | (2.15) |
Capex per Share |
(1.00) | (0.19) | (0.08) | (0.01) | 0.00 | 0.00 | 0.00 | (0.05) | 0.00 | (0.01) |
Free Cash Flow per Share |
0.33 | 0.97 | 0.27 | (0.14) | (0.13) | (0.19) | (0.18) | (0.12) | (0.07) | (2.16) |
Cash per Share |
2.57 | 1.39 | 1.06 | 0.88 | 0.88 | 1.32 | 1.32 | 2.83 | 2.83 | 0.04 |
Shareholders Equity per Share |
2.40 | 2.21 | 1.64 | 1.52 | 1.52 | 1.79 | 1.79 | (4.15) | 2.92 | 0.14 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.40 | 2.21 | 1.64 | 1.52 | 1.52 | 1.79 | 1.79 | (4.15) | 2.92 | 0.14 |
Free Cash Flow |
73.96 | 209.43 | 56.26 | (29.24) | (26.53) | (35.24) | (34.41) | (4.22) | (2.48) | (75.17) |
Working Capital |
363.21 | 174.46 | 176.59 | 168.65 | 168.65 | 190.68 | 190.68 | 97.86 | 93.93 | 0.68 |
Capital Expenditures |
(226.04) | (41.65) | (17.22) | (2.71) | (7.25) | (0.83) | (5.01) | (1.74) | (4.23) | (0.31) |
Net Current Asset Value |
(846.14) | 165.01 | 167.90 | 162.00 | 162.00 | 183.94 | 183.94 | (152.49) | 93.55 | (198.11) |
EV/EBIT |
72.90 | 79.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.10 | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
69.16 | 84.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.18 | 0.16 | 0.11 | 0.68 | 1.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
3.54% | 26.95% | 9.96% | (5.95%) | 0.00% | (6.06%) | 0.00% | 9.03% | (1.22%) | (1,154.71%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
5.24 | 4.52 | 4.16 | 4.55 | 0.00 | 4.86 | 0.00 | 9.72 | 0.00 | 2,051.51 |
Inventory Turnover |
8.50 | 6.98 | 7.13 | 6.73 | 0.00 | 7.88 | 0.00 | 11.09 | 0.00 | 0.00 |
Average Days of Payables |
85.14 | 109.70 | 100.10 | 99.94 | 94.00 | 106.38 | 100.32 | 74.90 | 72.94 | 0.18 |
Days of Inventory on Hand |
47.61 | 77.51 | 52.21 | 66.59 | 62.63 | 73.44 | 69.25 | 32.90 | 32.04 | 0.00 |
Average Receivables |
— | — | — | — | 3.40 | — | 2.16 | — | 2.16 | — |
Average Payables |
117.23 | 67.13 | 37.72 | 26.00 | 26.00 | 13.85 | 13.85 | 4.04 | 4.04 | 0.02 |
Average Inventory |
72.28 | 43.45 | 22.01 | 17.56 | 17.56 | 8.55 | 8.55 | 3.54 | 3.54 | — |
Average Assets |
1,431.12 | 574.36 | 403.76 | 393.46 | 393.46 | 269.64 | 269.64 | 161.73 | 161.73 | 102.38 |
Average Common Equity |
508.82 | 410.37 | 327.89 | 323.18 | 323.18 | 93.87 | 93.87 | (70.94) | (70.94) | 95.62 |
Columns are period end dates